Back to top

Image: Bigstock

Humana (HUM), Northwell Tie Up for Better Health Outcome

Read MoreHide Full Article

Humana Inc. (HUM - Free Report) recently inked a five-year deal with New York State’s leading healthcare provider Northwell Health that will bring in new services and products in the New York metropolitan area. The agreement is expected to result in better health outcomes. The deal will be effective Jan 1, 2021.

Northwell Health is also a leading private employer and has 23 hospitals, nearly 800 outpatient facilities and more than 14,200 affiliated physicians.

With the help of this transaction, Northwell will be able to combine its wide network and clinical quality with Humana’s reputation as a leader in Medicare Advantage. Both companies will work together to provide a Northwell retiree product for the next year and look forward to collaborate on products in the future.

Both entities will continue with the successful trend of clinical initiatives like enhancing Northwell’s House Calls program.

Undoubtedly, this move is in line with the health insurance giant’s commitment to improve benefits for its Medicare members.

Last month, Humana announced an array of 2021 Medicare product offerings, such as Medicare Advantage and Prescription Drug Plans, etc. Beneficiaries will now be able to choose from 69 new MAPD plans across various additional counties.

Humana will provide people under Medicare coverage with Humana Honor Medicare Advantage plans and even dispense the required health coverage to veterans for the second consecutive year. The company explored new locations for 2021 and even enabled safe enrolment for the beneficiaries.

Medicare Business and Its Scope

The health insurance giant always showed consistency when it comes to widening the scope of Medicare business.

Constant tie-ups to enrich medical care facilities are one of its key major commitments. The health care provider flaunts a strong Medicare business across the United States where it has been offering at least one Medicare plan across 50 states. Notably, it has been providing private health plans falling under the Medicare program for more than three decades now.

The COVID-19 outbreak coupled with an aging population in the United States further spurred demand for the Medicare Advantage plans. In order to reduce the financial burden imposed by the pandemic on its Medicare Advantage members, the company even eliminated additional costs for in-network primary care, outpatient behavioral health and telehealth visits for the rest of this year.

The business line’s growth track is evident from the 54% rise in Medicare membership from 2013 to 2018. Although the same dipped 1% in 2019, Individual Medicare membership climbed 17.1% year over year, which is a positive. The full-year individual Medicare Advantage membership is now anticipated to be around 375,000 members, up from the previous range of 330,000-360,000 members.

Over the past decade, the company saw maximum growth in Individual Medicare Advantage during 2019, which is pretty impressive.

Zacks Rank and Price Performance

Shares of this currently Zacks Rank #4 (Sell) company have surged 34.1% in a year compared with the industry’s growth of 26.6%.



You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Other companies in the same space, such as Centene Corp. (CNC - Free Report) , Anthem Inc. and Molina Healthcare, Inc. (MOH - Free Report)   have also rallied 27.5%, 17% and 70%, respectively, in the same time frame.

Biggest Tech Breakthrough in a Generation

Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.

A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.

See 8 breakthrough stocks now>>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Humana Inc. (HUM) - free report >>

Molina Healthcare, Inc (MOH) - free report >>

Centene Corporation (CNC) - free report >>

Published in